Stocks Hitting 52-Week Lows

shares fell 5.65 percent to touch a new 52-week low of $7.35. Bellicum Pharmaceuticals shares have tumbled 69.92 percent over the past 52 weeks, while the S&P 500 index has declined 3.44 percent in the same period.

shares reached a new 52-week low of $3.37. Credit Suisse maintained Vivint Solar with a Neutral and lowered the price target from $16.50 to $6.00. Goldman Sachs reinitiated coverage of Vivint Solar with a Sell rating and price target of $3.

shares touched a new 52-week low of $31.31. Endo International shares have dropped 62.93 percent over the past 52 weeks, while the S&P 500 index has declined 3.44 percent in the same period.

shares fell 7.33 percent to touch a new 52-week low of $10.74. Teladoc's PEG ratio is 2.93.